This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration

17 Jun
2024

A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning

Automated machine learning (AutoML)-based, data-driven, biomarker discovery pipeline approachReadmore

14 Aug
2024

Chris Berka on Advancing Early Detection of Neurodegenerative Diseases with EEG Biomarkers

The CEO and cofounder of Advanced Brain Monitoring discussed a study presented at AAIC 2024, which investigated the use of EEG biomarkers to distinguish between Alzheimer's disease and frontotemporal dementia.Readmore

22 Apr
2024

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease

NeuroSense Therapeutics Ltd. collaborate with Genetika+ for Alzheimer's Disease (AD) drug developmentReadmore

25 April
2024

Study Discovers Potential Biomarkers of Environmental Exposures in Parkinson’s Disease

A team of Northwestern Medicine investigators has discovered novel DNA methylation patterns in the blood of patients with Parkinson’s disease, according to findings published in Annals of Neurology. Readmore

03 July
2024

Scientists May Have Found How to Diagnose Elusive Neuro Disorder

The discovery of a unique pattern of proteins in the spinal fluid of patients may help with earlier diagnosis and new treatments for progressive supranuclear palsy.Readmore

5 Sep
2024

UCF Researchers Develop Rapid Test to Detect Dopamine

The sensor could serve as a low-cost and efficient tool for early detection of neurological disorders and conditions, including Parkinson’s disease, Alzheimer’s disease and depression.Readmore

30 Oct
2024

Silent Intruder: How the Cold Sore Virus Maps its Way Through the Brain

CU Anschutz researchers provide a better understanding of the long-term consequences of HSV-1 infectionReadmore

22 Aug
2024

Momentous occasion': UCL experts greet first drug approved for early Alzheimer’s disease in the UK

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer’s disease in the UK, following decades of work supported by UCL research.Readmore

14 MAY
2024

Olive oil may reduce risk of death from dementia

People who incorporate olive oil into their everyday diet may decrease their risk of dementia-related death, according to a new study by Harvard T.H. Chan School of Public Health.Readmore

08 JAN
2024

Life span increases in mice when specific brain cells are activated

Brain cells communicate with fat tissue to produce cellular fuel, counteract effects of agingReadmore

30 OCT
2023

Penn Medicine Receives $5 Million Grant to Study Next Generation of Dementia Treatments

Penn physicians and scientists will lead studies on underlying mechanisms of Alzheimer’s disease and related dementias with a grant from the Delaware Community FoundationReadmore

19 OCT
2023

Surgery-free brain stimulation could provide new treatment for dementia

A new form of deep brain stimulation offers hope for an alternative treatment option for dementia, without the need for surgery.Readmore

Subscribe to our News & Updates